Biohaven Ltd.
BHVNNYSEHealthcare● Active
$11.12
+$0.32(+2.96%)
Market Cap$1.2B
P/E Ratio—
52W High$18.566
52W Low$7.48
Biohaven Ltd. (BHVN) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BHVN · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 4, 2026EPS Actual
-$0.88
Est. -$0.86 · -2.3%
Revenue
—
Est. $0.00B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 4, 2026
After Market Close
▼ Miss EPS
BHVN reports quarterly as a NYSE-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.77 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 4, 2026 | -$0.86 | -$0.88 | -2.3% | — | $0.00B | — |
| — Q1 FY2026 | Mar 2, 2026 | -$1.22 | -$1.21 | +0.8% | — | $0.00B | — |
| ▲ Q4 FY2025 | Nov 10, 2025 | -$1.91 | -$1.64 | +14.1% | — | $0.00B | — |
| — Q3 FY2025 | Aug 11, 2025 | -$1.94 | -$1.94 | +0.0% | — | $0.00B | — |
| ▼ Q2 FY2025 | May 12, 2025 | -$1.67 | -$2.17 | -29.9% | — | — | — |
| ▼ Q1 FY2025 | Mar 3, 2025 | -$1.56 | -$1.85 | -18.6% | — | — | — |
| — Q4 FY2024 | Nov 12, 2024 | -$1.70 | -$1.70 | +0.0% | — | — | — |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.77
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 4, 2026Miss
EPS Actual
-$0.88
EPS Est.
-$0.86
EPS Surpr.
-2.3%
Revenue
—
Q1 FY2026
Mar 2, 2026
EPS Actual
-$1.21
EPS Est.
-$1.22
EPS Surpr.
+0.8%
Revenue
—
Q4 FY2025
Nov 10, 2025Beat
EPS Actual
-$1.64
EPS Est.
-$1.91
EPS Surpr.
+14.1%
Revenue
—
Q3 FY2025
Aug 11, 2025
EPS Actual
-$1.94
EPS Est.
-$1.94
EPS Surpr.
+0.0%
Revenue
—
Q2 FY2025
May 12, 2025Miss
EPS Actual
-$2.17
EPS Est.
-$1.67
EPS Surpr.
-29.9%
Revenue
—
Q1 FY2025
Mar 3, 2025Miss
EPS Actual
-$1.85
EPS Est.
-$1.56
EPS Surpr.
-18.6%
Revenue
—
Q4 FY2024
Nov 12, 2024
EPS Actual
-$1.70
EPS Est.
-$1.70
EPS Surpr.
+0.0%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $-0.76 | $-0.76 | $-0.76 | 3 |
| Q3 FY2028 | $-0.79 | $-0.79 | $-0.79 | 3 |
| Q2 FY2028 | $-0.80 | $-0.80 | $-0.80 | 3 |
| Q1 FY2028 | $-0.81 | $-0.81 | $-0.81 | 3 |
| Q4 FY2027 | $-0.63 | $-0.63 | $-0.63 | 2 |
| Q3 FY2027 | $-0.64 | $-0.64 | $-0.64 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 4, 2026 | -2.3% | $9.63 | $10.14 | +5.30% |
| ▲ Q1 FY2026 | Mar 2, 2026 | +0.8% | $11.52 | $11.81 | +2.52% |
| ▲ Q4 FY2025 | Nov 10, 2025 | +14.1% | $8.26 | $7.79 | -5.69% |
| ▲ Q3 FY2025 | Aug 11, 2025 | +0.0% | $14.74 | $13.41 | -9.02% |
| ▼ Q2 FY2025 | May 12, 2025 | -29.9% | $20.24 | $20.56 | +1.58% |
| ▼ Q1 FY2025 | Mar 3, 2025 | -18.6% | $37.18 | $32.06 | -13.77% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +0.0% | $52.43 | $50.36 | -3.95% |
| ▼ Q3 FY2024 | Aug 8, 2024 | -111.6% | $34.57 | $36.62 | +5.93% |
Q2 FY2026+5.30%
Report Date
May 4, 2026
EPS Beat/Miss
-2.3%
Price Before
$9.63
Price After
$10.14
Q1 FY2026+2.52%
Report Date
Mar 2, 2026
EPS Beat/Miss
+0.8%
Price Before
$11.52
Price After
$11.81
Q4 FY2025-5.69%
Report Date
Nov 10, 2025
EPS Beat/Miss
+14.1%
Price Before
$8.26
Price After
$7.79
Q3 FY2025-9.02%
Report Date
Aug 11, 2025
EPS Beat/Miss
+0.0%
Price Before
$14.74
Price After
$13.41
Q2 FY2025+1.58%
Report Date
May 12, 2025
EPS Beat/Miss
-29.9%
Price Before
$20.24
Price After
$20.56
Q1 FY2025-13.77%
Report Date
Mar 3, 2025
EPS Beat/Miss
-18.6%
Price Before
$37.18
Price After
$32.06
Q4 FY2024-3.95%
Report Date
Nov 12, 2024
EPS Beat/Miss
+0.0%
Price Before
$52.43
Price After
$50.36
Q3 FY2024+5.93%
Report Date
Aug 8, 2024
EPS Beat/Miss
-111.6%
Price Before
$34.57
Price After
$36.62
Avg Beat Reaction-4.04%
Avg Miss Reaction-0.24%
Beat Rate4 / 8 quarters
Largest Move-13.77% (Q1 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BHVN ends December
Biohaven Ltd. (BHVN) most recently reported earnings on May 4, 2026 for Q2 FY2026, posting EPS of $-0.88 — missing the analyst consensus of $-0.86 by -2.3%. The next BHVN earnings date is expected around September 1, 2026.
Each quarter, investors track BHVN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BHVN revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BHVN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BHVN earnings · 5 questionsBiohaven Ltd.'s next earnings report is expected around September 1, 2026. BHVN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BHVN historically reports after market close (AMC).
BHVN earnings datewhen is BHVN earningsBHVN next earnings datewhen does BHVN report earningsBHVN earnings calendar
▸ Source: FMP · Biohaven Ltd. SEC filings · US GAAP · Biohaven Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026